CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD)

Historical Holders from Q1 2019 to Q4 2025

Type / Class
Equity / COMMON STOCK, PAR V ALUE $0.001 PER SHARE
Symbol
CRMD on Nasdaq
Shares outstanding
79,310,345
Price per share
$11.63
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
43,129,899
Total reported value
$501,504,335
% of total 13F portfolios
0%
Share change
+8,999,573
Value change
+$101,838,520
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
189
Price from insider filings
$12.16
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Deep Track Capital, LP 6.3% $55,204,125 4,955,487 Deep Track Capital, LP 21 Nov 2025
SHAIBATALHAMD AYMEN ABDALKADER 5.8% -6.7% $44,390,000 -$440,330 4,600,000 -0.98% SHAIBATALHAMD AYMEN ABDALKADER 01 Jan 2026
BlackRock, Inc. 7.5% $41,659,221 4,567,897 BlackRock, Inc. 31 Dec 2024
As of 30 Sep 2025, CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) has 189 institutional shareholders filing 13F forms. They hold 43,129,899 shares. of 79,310,345 outstanding shares (54%) .

Top 25 institutional shareholders own 42% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
BlackRock, Inc. 7.2% 5,688,303 +6.1% 0% $66,154,964
VANGUARD GROUP INC 5% 3,977,658 -8% 0% $46,260,163
MARSHALL WACE, LLP 4.4% 3,473,494 +35% 0.04% $40,396,735
DEERFIELD MANAGEMENT COMPANY, L.P. 4.2% 3,323,833 0.59% $38,656,178
STATE STREET CORP 2.3% 1,835,621 +15% 0% $21,348,272
GEODE CAPITAL MANAGEMENT, LLC 2.3% 1,809,772 +13% 0% $21,050,228
CITADEL ADVISORS LLC 2.2% 1,717,087 +0.17% 0.02% $19,969,722
Alyeska Investment Group, L.P. 1.6% 1,262,979 +68% 0.04% $14,688,446
UBS Group AG 1.4% 1,090,908 +295% 0% $12,687,259
MORGAN STANLEY 1.1% 843,571 +9.9% 0% $9,810,737
OBERWEIS ASSET MANAGEMENT INC/ 0.99% 785,700 +62% 0.35% $9,137,691
Jump Financial, LLC 0.98% 774,083 0.12% $9,002,585
Nuveen, LLC 0.88% 695,724 -53% 0% $8,091,270
KENNEDY CAPITAL MANAGEMENT LLC 0.83% 658,633 +37% 0.17% $7,659,902
RAYMOND JAMES FINANCIAL INC 0.82% 651,987 +647% 0% $7,582,609
Qube Research & Technologies Ltd 0.8% 637,497 +196% 0.01% $7,414,090
NORTHERN TRUST CORP 0.78% 615,605 +8.5% 0% $7,159,486
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.74% 584,482 +199% 0% $6,797,526
Palisades Investment Partners, LLC 0.71% 564,106 +0.28% 2.6% $6,560,553
Deep Track Capital, LP 0.63% 500,000 0.16% $5,815,000
Invesco Ltd. 0.58% 456,908 +158% 0% $5,313,839
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.57% 448,425 +136% 0.01% $5,215,182
ROYCE & ASSOCIATES LP 0.56% 441,312 0.05% $5,132,459
October Effect Ltd 0.53% 420,551 +36% 5.4% $4,891,008
MILLENNIUM MANAGEMENT LLC 0.5% 395,454 +603% 0% $4,599,130

Institutional Holders of CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q4 401,205 $4,656,068 +$1,326,560 1,163% 8
2025 Q3 43,129,899 $501,504,335 +$101,838,520 1,163% 189
2025 Q2 34,151,234 $420,699,898 +$142,837,808 1,232% 169
2025 Q1 23,724,937 $146,235,596 +$397,499 616% 135
2024 Q4 22,893,836 $185,441,545 +$29,955,443 810% 126
2024 Q3 19,135,638 $154,655,147 +$21,831,393 808% 100
2024 Q2 17,129,390 $74,162,669 -$748,246 433% 97
2024 Q1 17,269,642 $73,216,929 -$5,693,027 424% 89
2023 Q4 18,742,007 $70,461,032 +$3,045,526 376% 101
2023 Q3 17,891,223 $66,197,207 -$5,485,628 370% 92
2023 Q2 19,187,043 $76,065,204 +$33,053,416 396.5% 86
2023 Q1 10,770,110 $44,582,136 -$1,863,278 414% 64
2022 Q4 11,182,776 $47,050,210 +$1,816,100 422% 62
2022 Q3 10,928,271 $31,131,890 -$4,497,215 282.88% 66
2022 Q2 12,425,504 $49,348,797 -$5,601,808 401.87% 69
2022 Q1 13,362,668 $73,354,516 +$1,886,576 548% 83
2021 Q4 13,046,114 $59,435,463 +$5,549,733 455.09% 78
2021 Q3 11,793,247 $54,910,109 +$1,590,384 465.1% 75
2021 Q2 11,351,356 $77,873,368 +$3,221,689 686.03% 77
2021 Q1 10,781,064 $107,630,096 +$16,345,897 999% 76
2020 Q4 9,261,298 $68,791,909 +$7,239,796 742.97% 74
2020 Q3 8,327,514 $50,205,664 +$9,581,252 603% 70
2020 Q2 6,739,459 $42,456,689 +$1,328,313 630.01% 67
2020 Q1 6,612,416 $23,732,293 -$6,155,816 358.6% 57
2019 Q4 6,440,146 $46,873,565 +$176,523 727.84% 62
2019 Q3 6,472,987 $41,291,108 +$6,489,686 638.01% 55
2019 Q2 5,421,031 $48,610,180 +$15,505,635 896.95% 45
2019 Q1 3,663,429 $34,616,000 +$34,616,000 944.84% 37